Blockchain BioPharma Tokenomics

The term "Tokenomics" refers to the economics of a crypto token, including its utility and governance features.
Post VC Funding, the Blockchain BioPharma DAO Executive Team sees the need to hire professional #Derivative and #Currency Designers with at least 30 Years of Experience Between them in the Legal, Regulatory, Compliance, and Currency Trading Space, Preferably at a Market-making Bank.
Blockchain BioPharma's ERC-20 Pharmaceutical Token (Ticker: PHARMA) holds the following Desirable Features for investors, DAO Voters, Owners, and Franchisees:
  • Pharmaceutical Token is a Derivative: "Deriving" in our case by the 50% Stake we hold in our entire eNFT or Enterprise Non-Fungible Marketplace for Medicines.
  • Pharmaceutical Token is a Utility Token. A utility token is a crypto token that serves some use case within a specific ecosystem. In the case of Blockchain BioPharma, it grants voting rights on the DAO, which will govern the company's operations. Ultimately, we envision Blockchain BioPharma becoming completely decentralized, with robust smart contracts that fulfill the mission of providing benefits to humanity in pharmaceuticals, nutrition, and life science.
  • Pharmaceutical Token is an #AltCoin. An AltCoin means cryptocurrencies other than Bitcoin and Ethereum.
REQUIRED READING: TOKENOMICS: DYNAMIC ADOPTION AND VALUATION - By Lin William Cogn, Ye Li, and Neng Wang